As shown in Figure 3, high expression HOPX showed worse disease-free survival in patients with brain lower grade glioma, kidney renal papillary cell carcinoma, prostate adenocarcinoma, stomach adenocarcinoma (STAD), and uveal melanoma, while high expression HOPX revealed good prognosis in head and neck squamous cell carcinoma patients. The gene discussed is HOPX; the disease is prostate adenocarcinoma.